Forderung des Einsatzes von PCR-Tests die ausschließlich auf Covid-19 reagieren

Причина блокування

Петиції, що містять неправдиві фактичні твердження, відсутні джерела або оманливе пропускання відповідних фактів, будуть закриті. openPetition залишає за собою право згодом запитувати джерела у спірних випадках або додавати важливі факти.

Bitte geben Sie Quellen (Links/URL) für folgende Aussagen an: "Die bisherigen PCR-Tests differenzieren bei den positiven Testergebnissen nicht zwischen Covid-19, Influenza, u.a." Ihre Aussage wird z.B. hier widerlegt: https://correctiv.org/faktencheck/2021/01/12/doch-corona-pcr-tests-koennen-sars-cov-2-von-erkaeltungsviren-zuverlaessig-unterscheiden/

Редакція openPetition поінформувала ініціатора петиції про порушення умов користування та надала п’ять днів для її перегляду. Це було неуспішно. Петицію було заблоковано.

Текст петиції

Die bisherigen PCR-Tests differenzieren bei den positiven Testergebnissen nicht zwischen Covid-19, Influenza, u.a.
Dadurch werden die tatsächlichen Zahlen der an Covid-19 Erkrankten verfälscht! Das muss sich ändern, damit z.B. ein korrekter Inzedenzwert niedergelegt werden kann! Davon hängt z.Zt. unser gesellschaftliches und wirtschaftliches Leben ab.

Bitte helfen Sie mit Ihrer Unterschrift mit, dass ab sofort nur noch Testverfahren zum Einsatz kommen, die differenziert von anderen Erkrankungen, Covid-19 austesten können und wir somit endlich ehrliche und korrekte Zahlen der tatsächlich an Corona erkrankten Menschen bekommen!
SARS-CoV-2 Coronavirus Multiplex RT-qPCR Kit (CD019RT) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Specificity non-specific interference of Influenza A Virus (H1N1), Influenza B Virus (Yamagata), Respiratory Syncytial Virus (type B), Respiratory Adenovirus (type 3, type 7), Parainfluenza Virus (type 2), Mycoplasma Pneumoniae, Chlamydia Pneumoniae, etc. Species Reactivity Human Application ,Qualitative, Size 100T Storage Intended Use All reagents should be stored at -30°C~-15°C with protection from light. The reagents are stable for 12 months when stored at the recommended condition. The expiration date will not change if the kit is opened and stored at the recommended condition. The expiration date will not change if the kit is transported with ice-packs for 4 days and/or treated with 10 freeze-thaw cycles. This product is intended for the detection of 2019-Novel Coronavirus (2019-nCoV). The detection result of this product is only for clinical reference, and it should not be used as the only evidence for clinical diagnosis and treatment. Principles of Testing This product is a dual-color multiplex fluorescent probe-based Taqman® RT-qPCR assay system. The Taqman fluorescent probe is a specific oligonucleotide based on a reporterquencher mechanism. For each probe, the 5'-end is labeled with a fluorophore, while the 3'-end was labeled with a quencher. When the probe is intact, the fluorescence emitted by the fluorophore is absorbed by the quencher, and no fluorescent signal is detected. However, during amplification of the template, the probe will be degraded due to the 5'-3' exonuclease activity of Taq DNA polymerase, and the fluorescent reporter and the quencher are cleaved and separated, then a fluorescent signal can be detected. The generation of each molecular amplicon is accompanied by the generation of a fluorescent signal. Real-time monitoring of the entire PCR process can be assessed by monitoring the accumulation of fluorescent signals. This product provides dual-detections of two independent genes of 2019-nCoV in a single tube. Specific primers and probes were designed for the detection of conserved region of 2019-nCoV's 45-1 Ramsey Road, Shirley, NY 11967, USA Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 Email: info@creative-diagnostics.com © Creative Diagnostics All Rights Reserved